chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Systemic: PARESTHESIA/NUMBNESS OF FACE AND LIPS-Mild, Systemic: Numbness (specify: facial area, extremities)-Medium, Additional Details: PATIENT NOTICED NUMBNESS OF RIGHT FACIAL AREA AND LIPS, STARTED TO SPREAD TO LEFT SIDE. PT. REPORTED THIS HAPPENED AFTER MODERNA VACCINE (BOTH DOSES). PT. WAS GIVEN LIQUID BENADRYL AND WAS RUNNING AROUND AFTER HER GRANDSON AFTERWARDS. PT. GIVEN BENADRYL PER PT. REQUEST AS THIS WAS GIVEN POST MODERNA VACCINE.
Cranky, crying, sleepy that afternoon. Very pale 5-6:00 P.M.. Slept during the night: woke up with temperature of 99.0 degrees Fahrenheit, vomitted 2-3 times, uncontrollable crying for 2 1/2 hours, then noticed the patient had hives. Then taken to the emergency room.
large amount of swelling inflamed, painful SOB on Pm 28MAY95; seen by MD in ER; 6JUN95 inj area still itches inflammation & swelling subsided;
Heart palpitations; This is a spontaneous report based on information received by Pfizer. Contactable other healthcare professionals and a consumer reported that a female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation; escitalopram oxalate (LEXAPRO), route of administration, start and stop date, batch/lot number and dose were not reported for major depressive disorder.  The patient medical history was not reported. The patient's concomitant medications were not reported.  Patient experienced heart palpitations after the Pfizer vaccine. The action taken in response to the event(s) for escitalopram oxalate was unknown. Outcome of the event was unknown.  The lot number for BNT162b2 was not provided and will be requested during follow up.
This case was reported by a consumer via call center representative and described the occurrence of muscle pain in a female patient who received Shingles vaccine for prophylaxis. On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced muscle pain, nausea, rash lips and feels awful. On an unknown date, the outcome of the muscle pain, nausea, rash lips and feels awful were unknown. It was unknown if the reporter considered the muscle pain, nausea, rash lips and feels awful to be related to Shingles vaccine. Additional details were provided as follows: The age at vaccination was not reported. The patient recently had the shingles vaccine. She felt awful and had tremendous symptoms. She had a lot of muscle aches and nausea and at the reporting time she had an outbreak on her lip. The patient enquired if the company had heard that before.
My heart was beating and fluttering so fast I was quite alarmed. It did stop a couple of seconds cans later I have been experiencing light fluttering.
Night sweats, 12 hours after vaccination [lasted 12 hours] Swollen lymph glands right neck and right side of tongue (Very slow rate- no trouble breathing), 2 days after [lasted 4 days] Swollen left side of tongue (very slow- no trouble breathing),  3 days after [lasted 3 days] Brain fog & fatigue- difficulty focusing or moving more quickly, 2 days after [lasted 4 days] Muscle aches and chills,  5 days after [lasted 1.5 days] Swelling, itching, pain, redness & heat in left lateral upper arm just below injection site, increasing in size approx 2/3 daily- currently 7?x4?, 6 days after [currently taking place, 3 days so far]
The patient said that the vaccinator hit a nerve while giving the vaccine causing her severe arm pain and inability to raise or move her arm following the vaccine.
unknown if directly related to COVID vaccine however patient presented 9/24/22 for symptoms of trigeminal neuralgia/nerve pain along (R) trigeminal nerve pathway & redness to (R) cheek. No vesicles to support clear Dx of herpes zoster.
I developed a parodic abscess and was admitted to the hospital and put on a bunch of different antibiotics. They did a procedure to try and drain the abscess. I am still on antibiotics for another week. I will follow up with my doctor.
pt recv vax; had high pitched crying starting about 4 hrs p/ vax given,lasting 4 hrs per mom;
Knots inside arm that recieved the shot and knot under skin around neck and upper back, and red, itching real bad.
Pt recv vax on 9/10/97; on 9/11/97 pt exp pruritus & erythema at vax site (120x80mm) w/ itching; tx=Advil, hydrocortisone cream & ice.
Phone call from mother at 8:15 am today. Reported that patient had difficulty standing last night related to soreness of his legs. About 8:00 pm, he began running a 102 degree temperature and she began alternating MOTRIN and TYLENOL throughout the night. Advised patient to place warm compresses to legs to help with muscle soreness and to contact her pediatrician for further recommendations. Mother immediately contacted the physician and reported that pediatrician stated that symptoms were expected side effects and to continue the MOTRIN and place in tub of warm water to soak legs and to apply warm compresses throughout the day. Asked mother to contact me via my cell number at any time.
it was rpt fr person concerning pt who was vax  & subsequently pt devel chickenpox
Round half dollar sized red, warm to the touch area below injection site starting nine days post injection.  Patient took Benadryl and ibuprofen last evening (01/20/21) and area has decreased in redness and warmth.  Patient encouraged to follow up with physician if concerned and/or redness or size increases .
Patient had fever (100.9 degrees), cold sweats, and redness on her arms. Two red areas (one on each arm), although not at injection site. Left arm received Fluzone HD, and red area was approximately 6 inches down from injection site. Prevnar 13 was administered in right arm, and red area was located about an inch below injection site.
pounding, throbbing headache w/ nausea and occular pain after 2nd dose in series. 3 days after 1st vax - h/a w/ coughing and sneezing. Diarrhea for 18-24 hrs. h/a 5 nights p/ 2nd dose. The day, gateral gaze painful; on 8/1,2 nausea,queezie
Patient started to experience itching on the lower left side of his back and thought he saw a rash so quickly went in to see the doctor. The doctor told him it is a localized Shingles reaction from the Shingrix vaccination he received and it should not spread any more from where it is now. Patient is experiencing pain and has been prescribed Valacyclovir for 7 days and Norco as needed to treat the reaction and help with the pain. the patient has a follow up visit with the doctor today and the doctor says he will keep the patient and our pharmacy up to date of the treatment.
on 6/20/05, more than one month after the 12 month vaccines, this child was seen for a fever and cbc was done. Platelet count was 32. She was not symptomatic and recovered to a normal platelet count over the next several months. She saw Hematology at Yale and they thought ITP was likely secondary to the MMR vaccine.
1st booster dose in aug2021 of 0.5 ml; This spontaneous case was reported by a consumer and describes the occurrence of ACCIDENTAL OVERDOSE (1st booster dose in aug2021 of 0.5 ml) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In August 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. In August 2021, the patient experienced ACCIDENTAL OVERDOSE (1st booster dose in aug2021 of 0.5 ml). At the time of the report, ACCIDENTAL OVERDOSE (1st booster dose in aug2021 of 0.5 ml) outcome was unknown.     No concomitant medication was provided. Patient stated that she was not immunocompromised. It was reported that patient had received her 1st booster dose 0.5 ml before as she states the 0.25 ml was recommended. She wanted to know if she had more protected because she got a higher booster dose and if the 2nd booster dose was ok for her to get now. Treatment medication was not provided by the reporter.
Headache Day 2-3 = foggy, HA, joint pain Narrative:  Other Relevant History:
positive COVID-19 test with symptoms; positive COVID-19 test with symptoms; The patient had MS and was immune compromised; The patient had MS and was immune compromised; This is a spontaneous report from a contactable consumer (patient). This female consumer of unspecified age received the first single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 04Jan2021, for COVID-19 immunization. She had MS and was immune compromised. Concomitant medications were not reported. On 07Jan2021 the patient woke up with headache, runny nose, groggy and muscle aches. She went to pharmacy and got a rapid COVID test that resulted positive. She was asking if the 1st dose could have caused her to be positive on the test. Events outcome was unknown.  Information on the batch/lot number has been requested.; Sender's Comments: Based on the information available, a possible contributory role of the suspect products cannot be excluded for the reported event of positive for corona virus infection for the lack of efficacy of the vaccine. However, based on the mechanism of action of the vaccine, it is unlikely the patient would have fully developed immunity for the vaccine to be effective, due to the number of days passed since the vaccine is given. Case will be reevaluated based on follow-up information
Asymptomatic Thrombocytopenia noted on routine labs prior to second vaccination. Still requires hematology follow-up and immunosuppression.
patient received the adjuvant part only of Arexvy on September 20th 2023; patient received the adjuvant part only of Arexvy on September 20th 2023; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a 67-year-old male patient who received RSVPreF3 adjuvanted (Arexvy) (batch number T2SV9, expiry date 29-JAN-2025) for prophylaxis.   On 20-SEP-2023, the patient received Arexvy. On 20-SEP-2023, an unknown time after receiving Arexvy, the patient experienced inappropriate preparation of medication (Verbatim: patient received the adjuvant part only of Arexvy on September 20th 2023) and inappropriate dose of vaccine administered (Verbatim: patient received the adjuvant part only of Arexvy on September 20th 2023).  The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK receipt date: 21-SEP-2023 The pharmacist (who remained anonymous) reported that patient received the adjuvant part only of Arexvy, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The vaccine administration facility is the same as primary reporter. The reporter did not consent to follow-up.
Demyelinating peripheral neuropathy compatible with Guillian-Barre Syndrome.  12/11/07 Reviewed hospital medical records which reveal patient experienced tingling & paresthesia of hands & feet starting approx 2 wks prior to admit & progressing to include lips & tongue.  Also developed balance & gait difficulty.  Denied any prior illness & had no problem w/flu shot in past.  Admitted 10/30-11/05/2007.  On admit, was areflexic & symmetrical sensory loss of UE & LE which worsened during hospitalization.  LP done.  Patient initially refused IVIG & plasmapheresis due to religious beliefs but during hospitalization did accept IVIG x 5 doses.  There was mild progression of weakness of LEs but no significant extension.  D/C to inpatient rehab. FINAL DX: demyelinating peripheral neuropathy c/w Guillain Barre syndrome.
Patient came into the pharmacy 8 days after the vaccine to report that a few days after getting the vaccine she had blood in her stool that looked like "you dumped a bucket of blood" in the toilet.   Patient has struggled with constipation since then.  Used old bisacodyl at home and had a little result but is still constipated.  Instructed the patient to call physician.  Paged her doctor office on call doctor for her and told her she may want to go to urgent care if needed.
Rash on neck upper chest and upper back; first noted approx 18 hrs after vaccines given.  Irritable, crying during night.  Given Tylenol, Benadryl given at clinic.  Rash resolved.
Information has been received from a physician concerning a 9 year old female who at few years ago was vaccinated injection with VARIVAX (Merck) 0.5ml (LOT# not provided). A few years after receiving VARIVAX (Merck), the patient experienced chicken pox. The patient was not recovered from chicken pox. It was reported that the patient sought unspecified medical attention. Additional information has been requested.
Sore Arm at injection site. Rash on Shoulder, Torso, and Neck.
Pruritic redness around neck and mild irritablilty seen in Emergency Room given Benadryl. Resolved symptoms in less than 24 hours with out worsening. Started 2-3 hours of vaccine administration. No erythema, shortness of breath, facial edema.
Ended up in the hospital paralyzed; This spontaneous case was reported by a consumer and describes the occurrence of PARALYSIS (Ended up in the hospital paralyzed) in a male patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     No Medical History information was reported.    On 11-Aug-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 12-Aug-2022,  after starting mRNA-1273 (Spikevax), the patient experienced PARALYSIS (Ended up in the hospital paralyzed) (seriousness criteria hospitalization and medically significant). At the time of the report, PARALYSIS (Ended up in the hospital paralyzed) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       Concomitant medication was not provided.  After the 24 hours of Moderna first dose, the patient experienced paralysis.  Treatment information was not reported.  Company Comment: This spontaneous case reported by a consumer concerns a male patient of unknown age, with no reported medical history, who experienced unexpected, serious (hospitalization, medically significant) event of paralysis, after receiving a first dose of mRNA-1273.  It was reported that 24 hours after vaccination, he ended up in the hospital paralyzed.  Further clinical course, diagnostic evaluation, concomitant medications, and treatment not reported.  The outcome was unknown.  The benefit risk relationship of mRNA-1273 is not affected by this report.     Reporter did not allow further contact; Sender's Comments: This spontaneous case reported by a consumer concerns a male patient of unknown age, with no reported medical history, who experienced unexpected, serious (hospitalization, medically significant) event of paralysis, after receiving a first dose of mRNA-1273.  It was reported that 24 hours after vaccination, he ended up in the hospital paralyzed.  Further clinical course, diagnostic evaluation, concomitant medications, and treatment not reported.  The outcome was unknown.  The benefit risk relationship of mRNA-1273 is not affected by this report.
Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) in an 85-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042J21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 16-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond 30 day use by date was given to 16 patients.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information provided. No treatment medication information provided.   Date the vial was initially stored in the refrigerator was 31 Jan 2022 The vial did not undergo any temperature excursion.   This case was linked to MOD-2022-525860.
Pregnant, due June 17th. The day after I got my second COVID vaccine dose, I felt  body aches, headache in the morning, and then terrible chest pain that evening. Everything went away the next day.
This spontaneous report was received from a lawyer regarding a case in litigation concerning an adult patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not reported. On an unknown date in 2013, the patient was inoculated, in a Health Center, with a dose of ZOSTAVAX as recommended for routine adult health maintenance and for the long-term prevention of shingles (strength, route, anatomical location, dose number, lot/batch # and expiration date were not reported). On or about 07-JUL-2015, the patient was treated in a Medical Center for the onset of a vesicular rash, which was diagnosed as herpes zoster or shingles. The vaccine did not prevent shingles as intended, and subsequently contracted a persistent strain of herpes zoster or shingles (vaccination failure). As a direct and proximate result of the ZOSTAVAX, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages (injury), and required extensive medical care and treatment. As a further proximate result, the patient had suffered and would continue to suffer significant medical expenses, and pain and suffering (emotional distress), and other damages (injury). At the time of reporting, the outcome of vaccination failure, herpes zoster, emotional distress, injury and pain was unknown. The reporter considered all the events to be related to ZOSTAVAX.
The flu shot injection was extremely painful. After receiving it I had constant pain at the injection site and limited use of that arm due to arm weakness/pain for about a month. The pain was worse at night. After about a month the pain decreased and rather than constant I would feel it occasionally throughout the day.  The pain sometimes was as far as 6 inches away from the injection site near the elbow or shoulder. About two months after the vaccination, I went several days without having pain. Then the pain started occurring again several times throughout the day. It's now been about 7 months since the vaccination and I still sometimes feel pain at or near the injection site if I lay it a certain way or after doing some exercises but now it's more like every couple of weeks that I feel it.
he developed, 102 fever the following day from the shots then followed by red red papules & vesicular lesions on his forearms, thighs, legs & trunk itching & 2 on face treated him with Benadryl/PO Calamine lotion & oatmeal Baths. getting better when I called today Feb/18/2020
0500 AM The injection site of Anthrax was a dime size, red, and burning in pain. By 1100 AM the injection site was as big at a .50 cent peice, red, burning in pain, and arm was swelling. I showed someone in my unit and he immediately took me to see a provider. I talked to the Physican Assistant at that time because I was experiencing sharp, shooting pain through my head, neck, and back. Along with my arm swelling, burning pain in my shoulder, and the redness was spreading. The PA told me "I wasn't having an allergic reaction because I could still breathe. He said he didn't have the pamphlet in front of him to tell me what the side effects were." He circled the red spot on my arm and told me if it got even bigger to come talk to him again. I was maybe in his office for 5 minutes. I had very bad pain through out the rest of the day. I couldn't turn my neck because the pain was so bad and my back was also in so much pain. I went to the Emergency Room by 2000/ 800PM that night. They didn't know how to treat for it. They treated me for pain and gave me Benadryl to take the swelling down in my arm. To this day 11/18/2015 I still have pain in my neck and back.
On 04/18/2021- the day after the vaccination, I notice on my right arm a red circle and it was hot and it kind of felt firm in the middle of it. I also felt like a truck hit me. After I took some Tylenol and slept, I recovered in 48 hours. I feel I recovered quickly because I had COVID-19 in 11/2020. I went to the urgent Care 2 or 3 days afterwards, because the bump kept swelling and the redness kept getting darker, and it just hurt every time I pushed on it. I tried ice on it, and nothing was helping. At the Urgent Care the doctor said it was a cellulitis infection. It hurt to move my arm with the big bump on it. It was a skin infection, and I was put on an antibiotic. It continued for a week and a half before it got better with the antibiotics and everything.
7 days after MMR vaccine administration, developed fever, low grade, which slowly worsened.  On 03/17/04, 9 days after vaccine, fever reached 104.4 and had a simple febrile seizure.  Was encephalopathic for next 2.5 days.  Seemed normal finally 3 days after seizure.  As can best be determined now, yes, pt recovered.
Diagnosed with COVID; Arm was swollen; Arm was throbbing; Arm was reddish-purple; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 30-Mar-2021 and was forwarded to Moderna on 30-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Diagnosed with COVID), PERIPHERAL SWELLING (Arm was swollen), PAIN (Arm was throbbing) and VACCINATION SITE ERYTHEMA (Arm was reddish-purple) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jan-2021, the patient experienced PERIPHERAL SWELLING (Arm was swollen), PAIN (Arm was throbbing) and VACCINATION SITE ERYTHEMA (Arm was reddish-purple). On 30-Jan-2021, the patient experienced COVID-19 (Diagnosed with COVID). On 08-Jan-2021, PERIPHERAL SWELLING (Arm was swollen), PAIN (Arm was throbbing) and VACCINATION SITE ERYTHEMA (Arm was reddish-purple) had resolved. At the time of the report, COVID-19 (Diagnosed with COVID) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient was on birth control medications. Treatment details included unspecified pain reliever for symptoms.
Bowel cramps with  tenesmus and changes of bowel movement with soft stools.
the patient had no symptoms or adverse events following administration; nurse who reports administration of vaccines following temperature excursion.; This spontaneous report has been received from a nurse referring to a patient of an unknown age and gender.  The patient's medical history, concurrent conditions, concomitant medications, and previous drug allergies or reactions were not provided.  On 29-JUN-2022, the patient was vaccinated with an improperly stored hepatitis b vaccine (recombinant) (RECOMBIVAX HB) at a dose of 0.5 milliliter once, lot number T032918 was determined to be valid for vial formulation for hepatitis b vaccine (recombinant) (RECOMBIVAX HB), expiration date: 12-NOV-2022 (vaccination scheme, and route of administration were not provided) as prophylaxis following a temperature excursion of minus 0.8 degrees Celsius (C) for 1 hour 10 minutes (product storage error), there was stated that no previous temperature excursion occurred. The patient had no symptoms or adverse events following administration of the vaccine.  This is one of several cases from the same reporter.
Migraine  Dizziness  Vertigo  Nausea  Vomiting